KATRD
LOGIN
- KATRD 2021 International Conference
-
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program in Detail
|
Oral Presentation 13 ILD 1 |
10:30-12:00 Ruby |
||
|---|---|---|---|
| Chair | Sun Mi Choi (Seoul National University, Korea) | ||
| 10:30-10:40 | OP 13-1 |
Clinical Outcomes of Dose Modification During Pirfenidone Treatment in Patients with IPF
Jieun Kang (Inje University, Korea)
|
|
| 10:40-10:50 | OP 13-2 |
The Efficacy of Pirfenidone in Combined Pulmonary Fibrosis and Emphysema (CPFE)
Hye Ran Gwon (Yonsei University, Korea)
|
|
| 10:50-11:00 | OP 13-3 |
Prevalence of and Risk Factors for Pulmonary Complications after Curative Resection in Idiopathic Pulmonary Fibrosis Patients with Early Stage Lung Cancer
Yunjoo Im (Sungkyunkwan University, Korea)
|
|
| 11:00-11:10 | OP 13-4 |
Validity of Pulmonary Artery to Aorta Ratio as a Predictor of Acute Exacerbation in Advanced Idiopathic Pulmonary Fibrosis Patients
Eun Young Kim (Yonsei University, Korea)
|
|
| 11:10-11:20 | OP 13-5 |
Serum Apolipoprotein A-I Predicts the Mortality in Patients with Idiopathic Pulmonary Fibrosis
Ganghee Chae (University of Ulsan, Korea)
|
|
| 11:20-11:30 | OP 13-6 |
Body Mass Index and Clinical Outcomes in Patients with Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study
Joon Han Kim (Seoul National University Bundang Hospital, Korea)
|
|
| 11:30-11:40 | OP 13-7 |
The Analysis of the Effect of Ischemic Heart Disease on the Clinical Course of IPF
Seung Hoon Kim (The Catholic University of Korea, Korea)
|
|
| 11:40-11:50 | OP 13-8 |
Non-tuberculous Mycobacterial Pulmonary Disease Increased the Risk of Hospitalization in Patients with Idiopathic Pulmonary Fibrosis
Jin-Young Huh (University of Ulsan, Korea)
|
|
| 11:50-12:00 | OP 13-9 |
Comparison of the Clinical Course of Patients with Idiopathic Pulmonary Fibrosis According to Their Smoking Status
Kwang Yong Choi (Seoul National University, Korea)
|
|
|
Oral Presentation 14 ILD 2 |
13:30-15:00 Ruby |
||
| Chair | Song Yee Kim (Yonsei University, Korea) | ||
| 13:30-13:40 | OP 14-1 |
Clinical Characteristics of Familial Idiopathic Pulmonary Fibrosis Patients in Korea
Sol Kim (Yonsei University, Korea)
|
|
| 13:40-13:50 | OP 14-2 |
Clinical Features between Cryptogenic and Secondary Organizing Pneumonia in a Single Hospital
Eun Jin Kim (Daegu Catholic University, Korea)
|
|
| 13:50-14:00 | OP 14-3 |
Clinical Factors Associated with Lung Function Decline and Mortality in Rheumatoid Arthritis-related Interstitial Lung Disease
Kangjoon Kim (Yonsei University, Korea)
|
|
| 14:00-14:10 | OP 14-4 |
Characteristics, Mortality, and Risk Factors in Patients with Systemic Sclerosis Associated Interstitial Lung Disease
Hye Jin Jang (Yonsei University, Korea)
|
|
| 14:10-14:20 | OP 14-5 |
Interstitial Lung Abnormality in Health Screening Examinees: Prevalence and Progression Rate
Jooae Choe (University of Ulsan, Korea)
|
|
| 14:20-14:30 | OP 14-6 |
Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases by Composite Physiologic Index
Jin Woo Song (University of Ulsan, Korea)
|
|
| 14:30-14:40 | OP 14-7 |
Diagnostic Performance of Digital Lung Auscultation for Interstitial Lung Diseases
Hanal Lee (Seoul National University Bundang Hospital, Korea)
|
|
| 14:40-14:50 | OP 14-8 |
Imaging Signatures in Idiopathic Pulmonary Fibrosis (IS-IPF) Study from Multi-center Multidisciplinary Experiences in Interstitial Lung Disease
Ju Hyun Oh (University of Ulsan, Korea)
|
|
| 14:50-15:00 | OP 14-9 |
Interstitial Lung Abnormality Evaluated by Automated Quantification System: Prevalence and Progression Rate
Ju Hyun Oh (University of Ulsan, Korea)
|
|
|
Oral Presentation 15 ILD 3 |
15:30-17:00 Ruby |
||
| Chair | Jin Woo Kim (The Catholic University of Korea, Korea) | ||
| 15:30-15:40 | OP 15-1 |
Blood KL-6 Predicts Disease Progression in IPF Patients Receiving Antifibrotic Therapy
Myeong Geun Choi (University of Ulsan, Korea)
|
|
| 15:40-15:50 | OP 15-2 |
Serum Krebs von den Lungen-6 (KL-6) as a Biomarker for the Disease Progression of Idiopathic Pulmonary Fibrosis
Chiwook Chung (University of Ulsan, Korea)
|
|
| 15:50-16:00 | OP 15-3 |
Diagnostic Value of Serum Vascular Endothelial Growth Factor-D in Korean Patients with Lymphangioleiomyomatosis
Hee-Young Yoon (Seoul North Medical Hospital, Korea)
|
|
| 16:00-16:10 | OP 15-4 |
Serum Proteomic Profiling of Rapid Disease Progression in Idiopathic Pulmonary Fibrosis
Kyung Hoon Chung (Seoul National University Bundang Hospital, Korea)
|
|
| 16:10-16:20 | OP 15-5 |
New Biomarker in Rapid Progressor of Idiopathic Pulmonary Fibrosis
Hye Ju Yeo (Pusan National University Yangsan Hospital, Korea)
|
|
| 16:20-16:30 | OP 15-6 |
Plasma Mitochondrial DNA as a Biomarker of Clinical Outcomes in Rheumatoid Arthritis-associated Interstitial Lung Disease
Jong Sun Park (Seoul National University, Korea)
|
|
| 16:30-16:40 | OP 15-7 |
Exogenous Tryptophan Aggravates Experimental Lung Fibrosis Through Activation of AKT-mTORC1 Pathway
Sung Woo Park (Soon Chun Hyang University, Korea)
|
|
| 16:40-16:50 | OP 15-8 |
Arachidonic Acid 12-lipoxygenase (ALOX12) Promotes Pulmonary Fibrosis
Gi Won Hwang (University of Ulsan, Korea)
|
|
| 16:50-17:00 | OP 15-9 |
Periostin is a Novel Biomarker for Chronic Lung Allograft Dysfunction after Lung Transplant
Hye Ju Yeo (Pusan National University Yangsan Hospital, Korea)
|
|